Cannabis Science Inc. (CBIS) Makes New Appointment to Advisory Board
Thursday, June 7th, 2012 | Filed under Internet,Technology | Posted by Adam Garcia
Cannabis Science Inc. (OTCBB: CBIS) stock is currently trading at $0.0730, up 21.67 percent from its previous close of $0.06. The stock today opened at $0.06 and touched the high of $0.0735 during the intraday trading. The stock’s lowest point during the day stood at $0.0601.
Cannabis Science announced that it has initiated the research program to discover the commercial aspects of its phytocannabinoid therapies for treating drug resistant HIV infection. The company said that it will also identify medicinal and structural biochemistry of its therapy. The research will be focused on the newly diagnosed patients suffering from HIV. The company also announced the appointment of Roscoe Moore to its Scientific Advisory Board. Dr. Moore has a Ph.D. in Epidemiology from the Johns Hopkins University.
Cannabis Science is a development stage company and is involved in the business of developing, producing and marketing pharma products. The company focuses on phytocannabinoid based therapies. Cannabis Science provides therapies to treat ailments like blood pressure, cancer and autism. Its therapies are also used to treat HIV infection and related problems. The company has a collaboration with Apothecary Genetics Investments LLC. Cannabis Science is based out of Colorado Springs in Colorado.
AI
